Literature DB >> 28496624

Assessing Patient Management and Outcomes in Atrial Fibrillation: Does your Health Insurance Plan know more than your Doctor?

Sanjeev Saksena1, April Slee2.   

Abstract

Entities:  

Year:  2009        PMID： 28496624      PMCID： PMC5398787          DOI： 10.4022/jafib.181

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  15 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.

Authors:  Nikolaos Dagres; Robby Nieuwlaat; Panos E Vardas; Dietrich Andresen; Samuel Lévy; Stuart Cobbe; Dimitrios Th Kremastinos; Günter Breithardt; Dennis V Cokkinos; Harry J G M Crijns
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

Review 3.  Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

Authors:  Matthew W Reynolds; Kyle Fahrbach; Ole Hauch; Gail Wygant; Rhonda Estok; Catherine Cella; Luba Nalysnyk
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

4.  Recent national patterns of warfarin use in atrial fibrillation.

Authors:  R S Stafford; D E Singer
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

5.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

6.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

7.  Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

Authors:  Mitchell K Higashi; David L Veenstra; L Midori Kondo; Ann K Wittkowsky; Sengkeo L Srinouanprachanh; Fred M Farin; Allan E Rettie
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

8.  National patterns of warfarin use in atrial fibrillation.

Authors:  R S Stafford; D E Singer
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

10.  The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.

Authors:  Carmella Evans-Molina; Susan Regan; Lori E Henault; Elaine M Hylek; Gregory R Schwartz
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.